المؤلفون: Osman, Sarah, Jeevanandam, Prakash, Kanakavelu, Nithya, Irvine, Denise, Lyons, Ciara, Jain, Suneil, Hounsell, Alan, McGarry, Conor

مصطلحات موضوعية: High-risk prostate cancer, SABR, VMAT, Flattening-filter-free (FFF), Pelvic lymph nodes irradiation

العلاقة: http://www.ro-journal.com/content/11/1/155Test

الإتاحة: http://www.ro-journal.com/content/11/1/155Test

المؤلفون: Valeriani, Maurizio, Carnevale, Alessia, Osti, Mattia, DE Sanctis, Vitaliana, Agolli, Linda, Maurizi Enrici, Riccardo

مصطلحات موضوعية: Hypofractionation, High risk prostate cancer, IMRT-SIB

العلاقة: http://www.ro-journal.com/content/9/1/214Test

الإتاحة: http://www.ro-journal.com/content/9/1/214Test

المصدر: Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer With PTEN Loss

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05593497Test

المصدر: Contribution of Canine Detection in the Diagnostic Strategy of High-risk Prostate Cancer

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05558735Test

المساهمون: Hongqian Guo, Chief Physician

المصدر: A Prospective, Multi-arm, Multi-center Clinical Trial on Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05406999Test

المساهمون: Ding-Wei Ye, Dr.

المصدر: Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05223582Test

المساهمون: Hongqian Guo, chief physician

المصدر: A Randomized, Controlled, Double-blind, Single Center，Clinical Trial to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05076851Test

المساهمون: Hongqian Guo, chief physician

المصدر: A Randomized, Controlled, Single Center Clinical Trial to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Androgen Deprivation Therapy Combined With Docetaxel for High Risk and Very High Risk Prostate Cancer

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04869371Test

المؤلفون: Prostate Cancer Canada

المصدر: Stereotactic Pelvic Brachytherapy With HDR Boost for Dose Escalation in High Tier Intermediate and High Risk Prostate Cancer (SPARE)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04236752Test

المساهمون: E. Brian Butler, Chair of Radiation Oncology Department, Houston Methodist Hospital

المصدر: Ferlay J, Sh HR, Bray F, Forman D, Mathers C, Park DM. Estates of worldwe burden of cancer 2008: GLOBOCAN 2008. t J Cancer. 2010 Dec 15;127(12):2893-917. do 10.1002/c.25516.
Zagars GK, Pollack A, KavadVS, von Eschenbach AC. Prostate-spec anten and radtn therapy for clally localed prostate cancer. t J Radt Oncol Bl Phys. 1995 May 15;32(2):293-306. do 10.1016/0360-3016(95)00077-C.
Al-MamganA, van Putten WL, van der Wlen GJ, Levendag PC, croccL. Dose escalatn and qualy of le patnts wh localed prostate cancer treated wh radtherapy: long-term results of the Dutch randomed dose-escalatn trl (CKTO 96-10 trl). t J Radt Oncol Bl Phys. 2011 Mar 15;79(4):1004-12. do 10.1016/j.robp.2009.12.039. Epub 2010 Apr 24.
Teh BS, Ayala G, Aguar L, MaWY, Tme TL, VlachakMT, Mes B, Kadmon D, Wheeler T, Calouet J, Dav M, Carpenter LS, Lu HH, Ch JK, Woo SY, Thompson T, Aguar-Cordova E, Butler EB. Phase trl evaluatg combed tensy-modulated radtherapy and su gene therapy wh or whout hormonal therapy treatment of prostate cancer-ter report on PSA response and bpsy data. t J Radt Oncol Bl Phys. 2004 Apr 1;58(5):1520-9. do 10.1016/j.robp.2003.09.083.
Teh BS, Aguar-Cordova E, VlachakMT, Aguar L, MaWY, Calouet J, Dav M, Mes B, Kadmon D, Ayala G, Lu HH, Ch JK, Carpenter LS, Woo SY, Grant WH 3rd, Wheeler T, Thompson TC, Butler EB. Combg radtherapy wh gene therapy (from the bench to the bedse): a novel treatment strategy for prostate cancer. Oncologt. 2002;7(5):458-66. do 10.1634/theoncologt.7-5-458.
Yossepowch O, Eggener SE, Bnco FJ Jr, Carver BS, Ser A, Scardo PT, Eastham JA. Radal prostatectomy for clally localed, hh rk prostate cancer: cral analys of rk assessment methods. J Urol. 2007 Aug;178(2):493-9; dcussn 499. do 10.1016/j.juro.2007.03.105. Epub 2007 Jun 11.
Freytag SO, Strker H, Pegg J, PallD, Pradhan DG, Peabody J, DePeralta-Ventura M, X X, Brown S, Lu M, K JH. Phase study of replatn-competent adenovus-medted double-sue gene therapy combatn wh conventnal-dose three-densnal conformal radtn therapy for the treatment of newly dgnosed, termedte- to hh-rk prostate cancer. Cancer Res. 2003 Nov 1;63(21):7497-506.
Freytag SO, Movsas B, Aref Strker H, Peabody J, Pegg J, Zhang Y, Barton KN, Brown SL, Lu M, Savera A, K JH. Phase trl of replatn-competent adenovus-medted sue gene therapy combed wh RT for prostate cancer. Mol Ther. 2007 May;15(5):1016-23. do 10.1038/mt.sj.6300120. Epub 2007 Mar 20.
Crook J, Ludgate C, Malone S, Perry G, Eapen L, Bowen J, Robertson S, Lockwood G. Fal report of multenter Canadn Phase randomed trl of 3 versus 8 months of neoadjuvant androgen depratn therapy before conventnal-dose radtherapy for clally localed prostate cancer. t J Radt Oncol Bl Phys. 2009 Feb 1;73(2):327-33. do 10.1016/j.robp.2008.04.075. Epub 2008 Aug 15.
Golden EB, Pellctta Demar S, Barcellos-Hoff MH, FormentSC. The convergence of radtn and munogen cell death snalg pathways. Front Oncol. 2012 Aug 7;2:88. do 10.3389/fonc.2012.00088. eCollectn 2012.
Gulley JL, Arlen PM, Bastn A, Mor S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Menard C, Camphausen K, Coleman CN, Sullan F, Steberg SM, Schlom J, Dahut W. Combg a recombant cancer vacce wh standard defe radtherapy patnts wh localed prostate cancer. Cl Cancer Res. 2005 May 1;11(9):3353-62. do 10.1158/1078-0432.CCR-04-2062. Erratum : Cl Cancer Res. 2006 Jan 1;12(1):322.
Kroemer G, GalluzzL, Kepp O, Zvogel L. munogen cell death cancer therapy. Annu Rev munol. 2013;31:51-72. do 10.1146/annurev-munol-032712-100008. Epub 2012 Nov 12.
Phase II Study Evaluating HSV-tk + Valacyclovir Gene Therapy in Combination With Androgen Deprivation Therapy, Brachytherapy, External Beam Radiotherapy, and Prostatectomy for High-Risk Prostate Cancer

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03541928Test